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Medical anthropologist Barbara Koenig spoke on the intersection of bioethics and genomics
at the 2009 Society for Medical Anthropology Conference at Yale University in New Haven,
Connecticut.
Medical anthropologist Barbara
Koenig is at the forefront of numerous en-
deavors that seek to understand race in the
ageofgenomicsandprotecthumansubjects
with regard to DNA repositories. Through
a dialogue ranging from the history and cri-
tiquesofbioethicstoherownresearchproj-
ects, Koenig brought her respect and
excitement for the anthropology found in
biomedicine to the 2009 Society for Med-
ical Anthropology conference at Yale Uni-
versity in September.
As a whole, the space in which
bioethics operates does not constitute a
“field” in the traditional sense. It is an
amalgam of approaches to the social, ethi-
cal, and cultural issues surrounding biology
and medicine. While the prevalent medical
ethic for 2,500 years has been understood
to be embodied in the Hippocratic Oath [1],
the modern age of biomedical research and
clinical practice demands more careful in-
spection of ethical issues in biology and
medicine. This precise space is where
bioethics has found fertile ground for in-
vestigation. For Koenig, anthropological
analysis and, more specifically, empirical
ethnographic study are critical tools to tease
apart the complexities of bioethical issues.
Recently, Koenig, a professor of med-
icine at the Mayo Clinic, has considered the
definitions of race in light of the emerging
work of genomics [2,3]. Her book, Revisit-
ing Race in a GenomicAge, argues that the
complex definitions of race are an interest-
ing blend of biological differences and cul-
tural traditions. Often in modern society,
the unity assumed among a racial group is
at odds with the underlying biological di-
versity revealed by genomics.And yet indi-
viduals in our species are much more
related to one another than, for example,
any two chimps are related. It is clear from
the much-cited work of the Human
Genome Project [4,5] and the International
HapMap Consortium [6] that genomics will
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have a deeply profound impact on how we
understand our ancestry and how easily indi-
viduals will be able to trace their own ori-
gins using modern genetic technologies.
Hints at new implications in personal-
izedmedicinealsohavecometolight,show-
ing that different patient populations,
distinguished by race, can have significantly
different responses to drugs [7,8]. Increas-
ingly,raceisusedasacategorizationtoparse
individuals for the purposes of biomedical
research. These categories are themselves
areas of contention, as they are socially con-
structed. Individuals may identify them-
selves with different racial categories
depending on the context in which the iden-
tifiers are provided. Furthermore, it is un-
clear what implications can be drawn from
the studies in which researchers are asked to
conclude something about a social identity
based on biological data. Research in these
areasundoubtedlywillprovideinsightfulan-
thropological analysis in the coming years.
Much of bioethics is concerned with the
issues surrounding new medical technologies
andtheirimpactonsociety.Inthissamevein,
theadventofsequencingdatabasesanddirect-
to-consumer genetic tests has had broad im-
plications for the participants. At the Mayo
Clinic,Koenigisworkingonthedevelopment
of a centralized biobank. This facility will
store DNA samples collected from patients
withawiderangeofdiseasesandenableeasy
access for clinicians and scientists interested
instudyingagivendisease.However,aswith
anycollectionofinformation,thereisaques-
tionofaccess.Whocanseewhatinformation?
How will this be regulated? And to what ex-
tent is informed consent required for each of
the future uses of the collected sample?
There has been much public debate re-
garding the ethical use of forensic DNA
databases [9,10] and yet less public consid-
eration concerning the medical DNA data-
bases. Koenig spoke of attempts to create
community understanding beyond the in-
formed consent standard.An auxiliary issue
related to the social impacts of new genetic
methods is the emergence of direct-to-
consumer genetic testing. Currently, certain
companies market to the public with the
promise of assessing the customer’s genetic
profile in order to identify genetic risk fac-
tors for disease.Without the intermediary of
a health care provider to validate the analy-
sis and contextualize the risk, these tests can
have an alarming and bewildering effect on
consumers. How should one understand an 8
percent increase in colorectal cancer risk rel-
ative to the general population? Certainly,
these new technologies and the companies
pushing them directly to the consumer pub-
lic are of profound anthropological interest.
While some anthropologists analyze
trends and conduct surveys to understand
their subjects, Koenig has entrenched herself
within the clinic and on advisory boards to
shape the outcome of bioethical issues fac-
ing our society in a time of ever-changing
technologies. She has done so with a firm
foundation in the historical perspective and
practical ethic of biomedicine.
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